Search Results - Jonathan Lambert
- Showing 1 - 5 results of 5
-
1
-
2
Dog Owners’ Perceptions of the Convenience and Value of Chewable Oclacitinib: Quantitative Survey Data from an International Survey by Andrea Wright, Andrew Hillier, Jonathan Lambert, Kennedy Mwacalimba, Natalie Lloyd, Tetsushi Kagiwada, Yoriko Hashiguchi, Carolyne Hours, Danielle Riley, Ashley Enstone, Robin Wyn
Published in Animals (2024-03-01)Get full text
Article -
3
Biallelic deleterious germline SH2B3 variants cause a novel syndrome of myeloproliferation and multi‐organ autoimmunity by Piers Blombery, Vahid Pazhakh, Adriana S. Albuquerque, Jesmeen Maimaris, Lingge Tu, Brenda Briones Miranda, Florence Evans, Ella R. Thompson, Ben Carpenter, Ian Proctor, Julie A. Curtin, Jonathan Lambert, Siobhan O. Burns, Graham J. Lieschke
Published in eJHaem (2023-05-01)Get full text
Article -
4
P1018: UPDATED RESULTS FROM MANIFEST ARM 2: EFFICACY AND SAFETY OF PELABRESIB (CPI-0610) AS ADD-ON TO RUXOLITINIB IN MYELOFIBROSIS by Marina Kremyanskaya, Claire Harrison, Prithviraj Bose, Vikas Gupta, Raajit K Rampal, Jonathan Lambert, Moshe Talpaz, Alessandro Vannucchi, Andrew Kuykendall, Jean-Jacques Kiladjian, Srdan Verstovsek, Ruben Mesa, Gozde Colak, Sandra Klein, Carmelita Alvero, John Mascarenhas
Published in HemaSphere (2023-08-01)Get full text
Article -
5
Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in the United Kingdom: A real‐world intention‐to‐treat analysis by Maeve A. O'Reilly, William Wilson, David Burns, Andrea Kuhnl, Frances Seymour, Ben Uttenthal, Caroline Besley, Rajesh Alajangi, Thomas Creasey, Shankara Paneesha, Johnathon Elliot, Carlos Gonzalez Arias, Sunil Iyengar, Matthew R. Wilson, Alison Delaney, Lourdes Rubio, Jonathan Lambert, Khalil Begg, Stephen Boyle, Kathleen P. L. Cheok, Graham P. Collins, Claire Roddie, Rod Johnson, Robin Sanderson
Published in HemaSphere (2024-06-01)Get full text
Article
